Order Article Reprints

González-Álvarez H, Bravo-Jiménez A, Martínez-Arellanes M, Gamboa-Osorio GO, Chávez-Gutiérrez E, González-Hernández LA, Gallardo-Ignacio K, Quintana-Romero OJ, Ariza-Castolo A, Guerra-Araiza C, et al. In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. Pharmaceuticals. 2021; 14(9):914. https://doi.org/10.3390/ph14090914

González-Álvarez, Héctor, Astrid Bravo-Jiménez, Matilda Martínez-Arellanes, Gabriela Odette Gamboa-Osorio, Edwin Chávez-Gutiérrez, Lino A. González-Hernández, Karina Gallardo-Ignacio, Osvaldo J. Quintana-Romero, Armando Ariza-Castolo, Christian Guerra-Araiza, and et al. 2021. "In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model" Pharmaceuticals 14, no. 9: 914. https://doi.org/10.3390/ph14090914

González-Álvarez, H., Bravo-Jiménez, A., Martínez-Arellanes, M., Gamboa-Osorio, G. O., Chávez-Gutiérrez, E., González-Hernández, L. A., Gallardo-Ignacio, K., Quintana-Romero, O. J., Ariza-Castolo, A., Guerra-Araiza, C., Martino-Roaro, L., Meneses-Ruiz, D. M., Pinto-Almazán, R., & Loza-Mejía, M. A. (2021). In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. Pharmaceuticals, 14(9), 914. https://doi.org/10.3390/ph14090914